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Ethnic Differences in Quality of Life in Persons with Heart Failure
Abstract
Background
Chronic illness burdens some groups more than others. In studies of ethnic/racial groups with chronic illness,
some investigators have found differences in health-related quality of life (HRQL), whereas others have not.
Few such comparisons have been performed in persons with heart failure. The purpose of this study was to
compare HRQL in non-Hispanic white, black, and Hispanic adults with heart failure.
Methods
Data for this longitudinal comparative study were obtained from eight sites in the Southwest, Southeast,
Northwest, Northeast, and Midwest United States. Enrollment and 3- and 6-month data on 1212 patients
were used in this analysis. Propensity scores were used to adjust for sociodemographic and clinical differences
among the ethnic/racial groups. Health-related quality of life was measured using the Minnesota Living with
Heart Failure Questionnaire.
Results
Significant ethnic/racial effects were demonstrated, with more favorable Minnesota Living with Heart Failure
Questionnaire total scores post-baseline for Hispanic patients compared with both black and white patients,
even after adjusting for baseline scores, age, gender, education, severity of illness, and care setting (acute vs.
chronic), and estimating the treatment effect (intervention vs. usual care). The models based on the physical
and emotional subscale scores were similar, with post hoc comparisons indicating more positive outcomes for
Hispanic patients than non-Hispanic white patients.
Conclusion
Cultural differences in the interpretation of and response to chronic illness may explain why HRQL improves
more over time in Hispanic patients with heart failure compared with white and black patients.
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Abstract 
Background: Chronic illness burdens some groups more than others. In studies of ethnic/racial 
groups with chronic illness, some investigators have found differences in health-related quality 
of life (HRQL) while others have not. Few such comparisons have been performed in persons 
with heart failure. The purpose of this study was to compare HRQL in non-Hispanic White, 
Black, and Hispanic adults with heart failure. 
Methods: Data for this longitudinal comparative study were obtained from eight sites in the 
Southwest, Southeast, Northwest, Northeast, and Midwest United States. Enrollment, 3-, and 6-
month data on 1,212 patients were used in this analysis. Propensity scores were used to adjust for 
sociodemographic and clinical differences among the ethnic/racial groups. Health-related quality 
of life was measured using the Minnesota Living with Heart Failure Questionnaire (MLHFQ). 
Results: Significant ethnic/racial effects were demonstrated, with more favorable MLHFQ total 
scores post-baseline for Hispanic compared to both Black and White patients, even after 
adjusting for baseline scores, age, gender, education, severity of illness, care setting (acute vs. 
chronic), and estimating the treatment effect (intervention vs. usual care). The models based on 
the physical and emotional subscale scores were similar, with post-hoc comparisons indicating 
more positive outcomes for Hispanics than non-Hispanic White patients.  
Conclusion: Cultural differences in the interpretation of and response to chronic illness may 
explain why HRQL improves more over time in Hispanic patients with heart failure compared to 
White and Black patients.  
 
Key words: heart failure, Hispanic, race, ethnicity, culture, quality of life, propensity analysis 
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Heart failure is common in the United States, regardless of ethnic or racial background. 
According to the National Health and Nutrition Examination Survey (NHANES) for the 1999 to 
2002 period, heart failure was found in 2.5% (men) to 1.9% (women) of the non-Hispanic White 
population, 2.7% (men) to 1.6% (women) of the Hispanic population, and 3.1% (men) to 3.5% 
(women) of the non-Hispanic Black population.
1
 These rates rise significantly with age. 
Eliminating health disparities among different ethnic/racial groups is a major goal of 
Healthy People 2010. Ethnicity and race refer to families, tribes,
 
peoples, or nations belonging to 
the same common stock, or a class
 
or kind of people unified by shared interests, habits, or 
characteristics.
2
 The unequal burden of chronic illness has caused some ethnic/racial groups to 
have more symptoms, worse functional disability, and lower health-related quality of life 
(HRQL) than others. In studies of HRQL by ethnic/racial groups, some investigators found 
differences but others did not.
3-5
 Since few comparisons of HRQL by ethnicity/race have been 
performed in persons with heart failure, the burden of heart failure experienced by various 
ethnic/racial group is unknown.  
The purpose of this study was to compare HRQL in a sample of non-Hispanic White, 
non-Hispanic Black, and Hispanic adults with heart failure. We hypothesized that differences in 
HRQL would exist among these groups based on our earlier work.
6
 Health-related quality of life 
refers to the perception of how illness influences one’s physical, emotional, and social well-
being.
7
 Physical and emotional components of HRQL were compared to identify specific 
problematic areas or mechanisms for differences. Knowing how different ethnic/racial groups 
experience heart failure would help focus education and intervention content. 
Methods 
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Data for this longitudinal comparative study were obtained from a registry of heart failure 
quality of life (The Heart Failure Quality of Life Trialists Collaborative) contributed to by 
investigators from eight sites representing the Southwest, Southeast, Northwest, Northeast, and 
Midwest sections of the United States. Some sites were in large urban areas and others were in 
mid-sized cities. The settings where recruitment occurred represented the range of possibilities: 
community hospitals, tertiary care centers, a federal health care system, and outpatient clinics 
that were both specialty and general in focus. No one setting was over-represented. Most 
participants had been enrolled during an acute hospitalization (56%), with the remaining 
respondents were enrolled in a chronic care setting. The different recruiting sites introduced 
heterogeneity into the sample that was controlled by including type of enrollment setting in the 
propensity score model.  
Sample 
Enrollment, 3-, and 6-month data on 1,212 patients were used in this analysis. The 
inclusion criteria were similar at all sites. Only patients with an established diagnosis of chronic 
heart failure documented in the medical record by a physician provider were included. Patients 
were excluded if they had an acute myocardial infarction, unstable angina, cognitive impairment, 
or severe psychiatric problems, or were discharged to an extended care or skilled nursing facility 
or were homeless. Three investigative teams formally tested cognitive function with the Mini-
Mental State Examination or the Pfeiffer Short Portable Mental Status Questionnaire and others 
used clinical criteria to exclude patients who were unable to complete questionnaires and 
participate in data collection. Subjects of Hispanic descent were enrolled primarily at the 
Southern California sites, 99% of which were persons of Mexican ancestry. Ethnicity/race was 
self-reported in all studies. Self-identification of ethnicity and race is problematic, but the best 
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method available at this time.
8
  
Some studies in the registry were observational assessments of usual care. Others were 
studies of behavioral, nonpharmacologic interventions such as education, counseling, and self-
care monitoring. To adjust for the influence of having received an active intervention on HRQL, 
patients were categorized as receiving “treatment” or “usual care” and this variable was included 
as an adjusting factor in the longitudinal analysis.  
To evaluate our logic of combining the interventions into a single “treatment” group, we 
assessed treatment group means and the variability in scores. As expected, the intervention 
subjects had greater improvement in HRQL compared with controls over the 6-month study 
period; the average change in HRQL between baseline and 6-months was 22.9 for the treatment 
group, and 12.5 for controls. Although the treatment group was comprised of subjects exposed to 
different behavioral interventions, the degree of variability in this group was not greater than 
within the cohort of controls. The test for equality of variances for baseline HRQL was not 
significant (the treatment SD 24.8 compared with 24.5 for the control group). Tests of equality of 
variances at 3- and 6-months were also nonsignificant: the standard deviations at 3-months for 
the intervention and control groups were 25.3 and 25.6, respectively; at 6-months the standard 
deviations were 24.0 for intervention and 25.7 for control. These findings indicate that while 
treatment group respondents may have responded differently to the various interventions they 
received, as a group their response to study participation exhibited the same range of variability 
as found in the more homogenous group of control subjects.  
Measurement 
Health-related quality of life was measured using the Minnesota Living with Heart 
Failure Questionnaire (MLHFQ), a 21-item disease-specific measure of HRQL. The MLHFQ 
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measures overall well-being and two HRQL domains: physical limitations and emotional 
responses. English and Spanish versions of the MLHFQ were used in this study. Participants 
were given the choice to complete the instrument by themselves or to have it read to them by 
fluently bilingual research staff. The Spanish version had been translated professionally and back 
translated to English by fluent Spanish speakers residing in the region where the data were 
collected to assure that the local idioms (i.e., phrases and terms used in Southern California) 
were appropriate. The MLHFQ has been shown repeatedly to be internally consistent (with alpha 
coefficients usually >.90 in clinical samples) and stable over a short period of time.
9-11
 For the 
total scale score and for both the physical limitations and emotional responses subscales, lower 
scores on the MLHFQ indicate better health-related quality of life. 
Severity of illness was measured using New York Heart Association (NYHA) class. 
Technically, NYHA class is a measure of functional status,
12
 but others have shown that higher 
NYHA class is associated with increased mortality and hospitalization rates in persons with heart 
failure.
13
 
Procedure and Analysis 
The primary investigator obtained Institutional Review Board approval for this 
comparison in addition to the approval obtained at each individual site. De-identified data on 
HRQL, group assignment (treatment or usual care), setting where enrolled (acute or chronic), 
ethnic/racial group, age, education, and NYHA functional class were submitted to a central site 
where it was integrated, reviewed for accuracy, and analyzed. From the full data set of 1,490 
patients, subjects with baseline and at least one follow-up MLHFQ score were retained for this 
analysis.  
Descriptive statistics were used to summarize the data. Group differences in the 
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demographic and clinical characteristics, as well as baseline HRQL, were determined using one-
way analysis of variance (ANOVA), two-sample t-tests or chi-square tests, as appropriate. 
Comparisons among ethnic/racial groups, between treatment groups, and between those retained 
or not retained for this analysis, were made using these techniques.  
Comparing demographic and clinical characteristics of the 1,212 subjects in the analysis 
and the 278 subjects in the registry who were not included in the analysis, subjects in this 
analysis were significantly younger (M = 66.1 vs. M = 68.4; t = 2.4, p = .02), more likely to have 
at least some post-secondary education (χ2 = 10.7, p = .005), and more likely to have received an 
active intervention rather than usual care (χ2 = 99.6, p < .0001). A larger proportion of those 
enrolled from a chronic care settings were included (93%), while only 74% of those enrolled 
from an acute care setting were included (χ2 = 84.9, p < .0001). There were no differences in 
gender, ethnic/racial group, or NYHA class between those included or not included in the study.  
The Black, White, and Hispanic groups differed in several characteristics. The three 
ethnic/racial groups differed in mean age (F = 46.5, p < .0001); Black patients were significantly 
younger (M = 58.4) than either the White (M = 68.0) or Hispanic patients (M = 67.6). Significant 
ethnic/racial group differences were also found in gender, education, care setting (acute vs. 
chronic), and NYHA class (see Table 1), but the percentage of treatment participants did not 
differ across the three ethnicities.  
Propensity scores minimize bias that may occur when making comparisons among 
groups that are dissimilar on demographic or clinical characteristics.
14
 Using the variables that 
demonstrated significant ethnic/racial differences, propensity scores were determined with 
logistic regression and these scores were used as a covariate in subsequent analyses. The 
methodology requires that ethnicity/race has only two levels, since probabilities can only be 
  Ethnic Differences HRQL 
 8 
determined in logistic regression for binary outcomes. In this study, the propensity score is the 
probability, with a potential range of zero to one, of being a member of a particular ethnic/racial 
group given the profile of demographic and clinical characteristics.  
The Hosmer-Lemeshow goodness-of-fit test was used to determine how well each model 
fit the data; for this test, large p-values are desired since these correspond to a nonsigificant lack 
of model fit. The area under the receiver operating characteristic (ROC) curve was assessed as a 
measure of how well each logistic model discriminated between the ethnic/racial groups. The 
ROC curve is a plot of the sensitivity versus 1-specificity. The area under the curve can range 
from 0 to 1, with values closer to 1 indicating a higher degree of accuracy of the model in the 
ability to discern between the two ethnic/racial groups being compared, based on the values of 
the predictor variables. 
Repeated measures analysis of covariance (ANCOVA) was used to compare HRQL 
among the ethnic/racial groups over time, adjusting for baseline MLHFQ score and the 
propensity scores. Although not the focus of this analysis, treatment group (intervention vs. usual 
care) was included as a factor in these longitudinal models because the interventions were 
designed to influence HRQL. Since propensity scores are determined for two ethnic/racial 
groups at a time, three ANCOVA models were developed, one for each pair of the three groups. 
Each model included time (3- and 6-months), ethnicity/race (two groups), treatment group 
(control and intervention), and the two-way and three-way interactions of these factors. Post-hoc 
analysis was based on Fisher’s least significant difference procedure for pairwise comparisons.  
Patients were retained in the study if they had the baseline MLHFQ score and at least one 
of the two follow-up scores. Some of these subjects were omitted from the longitudinal analysis 
because they were missing one or more of the demographic and clinical characteristics used to 
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calculate the propensity scores (5% of the sample, n = 56). Since the propensity scores (PS) were 
used as a covariate in the repeated measures models, any subject missing the PS was omitted 
from the longitudinal analysis. There was no difference in baseline MLHFQ between those who 
were included in the longitudinal study and those who were not (because their PS could not be 
determined). All of the remaining 1,156 subjects were included in two of the three repeated 
measures models (corresponding to their ethnic group), even though 42% were missing from one 
of the two follow-up assessments based on the original study design. The SAS procedure used 
for the repeated measures analysis, PROC MIXED, is particularly appropriate for longitudinal 
studies where dropouts are not uncommon,
15
 assuming the incomplete data are missing at 
random. Since there was no difference in baseline MLHFQ scores between those who had 
complete data and those who were missing one of the two follow-up scores, this assumption is 
reasonable.  
  All analyses were done using SAS for Windows, version 9.1 (SAS Institute, Inc., Cary, 
NC). An alpha level of .01 was used throughout to control for the overall Type I error rate 
associated with multiple comparisons.   
Results 
Most of the 1,212 participants were male (54%) and non-Hispanic White (63%); the non-
White patients were split nearly equally between Black (19%) and Hispanic (18%) patients. The 
mean age overall was 66.1 (SD = 14.0), with a range from 20 to 96 years. Slightly more than 
one-third (36%) of the sample had less than a high school education, while the remaining 
subjects were split between high school graduates (32%) and those with some post-secondary 
education (32%). The most common level of physical functioning was NYHA class III (44%), 
with 32% in class II and 24% in class IV. The sample was split between the treatment (48%) and 
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usual care (52%) conditions. There was no difference by ethnicity/race in the percentage of 
patients assigned to the treatment or usual care groups. Importantly, there was no difference 
among the three ethnic/racial groups in baseline MLHFQ scores.  
 Each of the three propensity score models fit the data well, as evidenced by 
nonsignificant p-values in each case (Table 2). The area under the curve was high for each of the 
models, suggesting that the propensity scores captured the differences between each ethnic/racial 
pair accurately and that the scores are based on models that fit the data adequately. 
Repeated measures analysis of covariance  
Mean MLHFQ scores improved over time in all the ethnic/racial groups, but most 
dramatically among Hispanics (Figure 1). Both models of the total MLHFQ score that included 
Hispanic participants demonstrated a significant ethnic/racial effect (Table 3). The post-hoc 
analysis demonstrated more favorable MLHFQ total scores post-baseline for Hispanic compared 
to White patients, even after adjusting for MLHFQ total score at baseline, treatment group, and 
differences in demographic and clinical characteristics between the ethnic/racial groups. The 
least squares mean, which is adjusted for covariates, differed significantly between Hispanic and 
White patients post-baseline (t = 7.6, p < .0001). When Black and Hispanic patients were 
compared, adjusted total scores differed significantly as well (t = 2.9, p = .004). 
The physical and emotional subscale score models demonstrated a significant 
ethnic/racial effect (Table 3). When comparing Hispanics and Whites, the Hispanics had more 
positive outcomes. On post-hoc analysis, the least squares mean indicated significant differences 
in physical (t = 6.4, p < .0001) and emotional (t = 6.4, p < .0001) subscale scores post-baseline 
between Hispanic and White participants.  
When Hispanic and Black patients were compared, only total MLHFQ scores differed 
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between them post-baseline (Table 3), with Black patients reporting poorer total HRQL 
compared with Hispanic patients (t = 2.9, p = .006). No Black vs. White patient difference was 
significant for any of the three MLHFQ outcomes.  
Discussion 
 
The major finding of this study was that HRQL improved more over time in Hispanics 
with heart failure than White or Black samples after controlling for demographic, clinical, and 
treatment group differences among the three major ethnic/racial groups. The differential 
improvement in HRQL seen in the Hispanic sample is consistent with our prior comparison of 
Hispanic and non-Hispanic White patients with heart failure.
6
 In that study, we matched 
Hispanic and White patients on functional status and age and compared scores obtained using the 
same measure of HRQL over a six month period following hospital discharge. We found that 
Hispanic patients, some of the same patients used in this analysis, improved more over time than 
White patients. However, without a good explanation for the phenomenon, possible spuriousness 
of the results due to inadequate matching was considered.  
In this comparison, propensity scores were used to statistically adjust for differences in 
multiple demographic and clinical characteristics that may have unduly influenced our prior 
findings. In addition, the treatment effect was accounted for in the analysis. Also, a third group 
of heart failure patients—non-Hispanic Blacks—was added to the comparison. Using these 
methods, we feel confident that the significant differences demonstrated in this analysis can be 
attributed to true group differences in MLHFQ scores rather than an artifact of group differences. 
Few prior investigators have compared HRQL in ethnic/racial groups. Results from a 
population survey conducted between 1993 and 2002, the HRQL surveillance project from the 
National Center for Chronic Disease Prevention and Health Promotion, revealed few differences 
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among Hispanic, non-Hispanic Black and non-Hispanic White persons in perceived health, 
mental or physical functioning.
16
 In medically ill samples, Jackson-Triche and colleagues
4
 found 
that physical functioning scores on the SF-36 were highest (best) in Hispanics, lowest in Blacks, 
and in the middle in non-Hispanic Whites, similar to our results.  
One explanation for our finding that HRQL improved more over time in Hispanics than 
non-Hispanic Whites and Blacks with heart failure is an inaccurate perception about the 
chronicity of the illness in the Hispanics. When Becker and colleagues
17
 compared views about 
chronic illness in Hispanic, Black, and Filipino persons, they found that many Hispanics believed 
that symptom remission was a cure and each exacerbation of symptoms was a separate illness 
unrelated to prior episodes. Black persons in their study held mainstream cultural views about 
chronic illness. It may be that the Black and White patients in the current study realized that 
heart failure was a chronic illness that can only be controlled, while the Hispanic patients 
believed that symptom remission indicated that they were cured. If true, disease-specific HRQL 
would be expected to improve over time in individuals who believed that the problem had 
resolved. Much has been written about the Hispanic paradox, which refers to the epidemiologic 
finding that Hispanics in the U.S. tend to paradoxically have significantly better health than the 
average population, in spite of what their aggregate socioeconomic indicators would predict.
18
 
The specific cause of this phenomenon is poorly understood, but a mistaken perception about the 
meaning of illness may be protective in some fashion. It should be noted, though, that 
misperceptions about chronic illness are not limited to the Hispanic population; the same 
phenomenon has been noted in other populations.
19, 20
 
Another explanation for why HRQL is better in Hispanics could be inner strength. In one 
study, older Hispanic women described drawing strength from their past, focusing on 
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possibilities, being supported by others, knowing their purpose, and nurturing the spirit as 
characteristics that contributed to their inner strength and ability to cope with illness.
21
 This 
optimism was reflected in another study of Mexican-American families with chronically ill 
children.
22
 Family members took spiritual and secular actions to assure the best possible care for 
the ill child and sought to influence God's good will on behalf of the child and the family. 
Perhaps, over time, the Hispanic patients in this sample refocused themselves in this fashion and 
thereby improved their HRQL.  
Another interpretation is related to language. Even though the Hispanic sample 
completed the instrument in their native language, it is plausible that the meaning given to the 
responses was interpreted differently. Others have noted that the lexicon of illness terms used by 
Hispanics in the US is affected by the practice of speaking both Spanish and English and by their 
experiences with different health systems.
23
 
It is also possible that social desirability of responses among Hispanics influenced the 
results. That is, it could be that the Hispanics in the sample felt inclined to present themselves in 
a manner that would be viewed favorably by others. However, if such an explanation is true, we 
have no explanation about why they responded in a fashion comparable to the other groups at 
baseline.  
It was surprising that the physical component of HRQL was not significantly different for 
Black patients compared with either of the other ethnic/racial groups, considering prior studies. 
Others have found that physical decline may be more pronounced in ill Blacks than in ill Whites. 
For example, Clarke and colleagues
24
 found that the risk of experiencing significant functional 
decline was approximately doubled in non-White patients with systolic dysfunction at one year. 
In work by Ferraro and colleagues, more rapid functional decline was observed in Black patients 
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over a 15-year period than in Whites and others, even when illness was taken into account.
25, 26
 
Others have suggested that socioeconomic status may explain differences in physical functioning 
among Blacks compared to other ethnic/racial groups.
27
 Since the propensity score method 
controlled for sociodemographic differences, use of this strategy in the present study may explain 
why the differences in physical HRQL between Blacks and others were not significant.  
The primary limitation of this study is that it was a secondary analysis of existing data. 
These results are not generalizable to all patients with chronic heart failure since the patients in 
this analysis were younger and more likely to have some post-secondary education than those not 
included in the analysis. The Hispanic sample was primarily of Mexican origin, so these results 
may not apply to Hispanics from other countries. The instrument used here to measure HRQL 
has been shown to be less sensitive than other measures of HRQL, so the extent of differences 
may be underestimated.
28
 Another limitation was that the samples received different treatments 
at the various sites. However, the treatments were all behavioral in nature and treatment was 
controlled both as a predictor in the propensity scores and as a factor in the longitudinal analyses. 
An additional limitation was that variables that could further explain these differences, such as 
illness perceptions, social support, and spirituality were not measured. It is also possible that a 
cultural bias exists in the data obtained from the MLHFQ, but this seems unlikely since there 
were no differences in baseline scores and it was evident only on repeated assessment.   
Strengths of the study include the methodological control introduced with the use of 
propensity scoring. Some authors have refuted the Hispanic Paradox concept, arguing that the 
apparent advantage reflects selection bias and poor methodological control of confounding 
variables.
18
 Based on the methodological controls used, we conclude that a true difference in 
HRQL exists among the ethnic/racial groups studied. Whether or not the difference seen is 
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related to heart failure cannot be stated with certainty, but use of longitudinal data strengthens 
our confidence in the conclusion that the response to heart failure appears to differ over time 
among the ethnic/racial groups studied.  
The question of whether Hispanics improve more in HRQL over time because of 
inaccurate perceptions about illness chronicity, some inherent cultural strength, or differences in 
language remains the charge of future investigators. If there is something unique about the 
Hispanic culture that promotes positive HRQL, a greater understanding of how Hispanic culture 
promotes positive HRQL could bolster intervention strategies for all patients with heart failure.  
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Figure 1. Average Scores on the Minnesota Living with Heart Failure Questionnaire by Time 
and Ethnic/Racial Group (N=1,212) 
 
 
 
Figure Legend: Total and subscale scores are compared based on ethnic/racial group, regardless 
of assignment to treatment or usual care group; lower scores on the MLHFQ instrument indicate 
better HRQL. 
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Table 1. Summary of demographic and clincal characteristics by ethnicity and comparisons 
among ethnic groups (N = 1,212). 
 
 
 
Characteristic 
 
White 
 
(n = 767) 
 
n (%) 
 
Black 
 
(n = 231) 
 
n (%) 
 
Hispanic 
 
(n = 214) 
 
n (%) 
 
Group comparison 
 
 
χ2 
 
Gender 
Female 
Male 
 
Education 
< High school 
High school graduate 
Some college 
 
Setting 
Acute 
Chronic 
 
NYHA Class 
  II 
  III 
  IV 
 
Group 
Control group 
Intervention group 
 
 
 
448 (58) 
319 (42) 
 
 
207 (28) 
249 (33) 
293 (39) 
 
 
450 (59) 
317 (41) 
 
 
241 (32) 
331 (45) 
169 (23) 
 
 
387 (50) 
380 (50) 
 
 
100 (43) 
131 (57) 
 
 
86 (38) 
93 (41) 
46 (21) 
 
 
46 (20) 
185 (80) 
 
 
102 (45) 
98 (43) 
28 (12) 
 
 
134 (58) 
97 (42) 
 
 
 
107 (50) 
107 (50) 
 
 
133 (62) 
44 (21) 
36 (17) 
 
 
180 (84) 
34 (16) 
 
 
34 (16) 
94 (44) 
84 (40) 
 
 
106 (50) 
108 (50) 
 
 
18.1** 
 
 
 
107.9** 
 
 
 
 
192.7** 
 
 
 
64.0** 
 
 
 
 
4.6 
 
 
 
* p < .01; ** p < .0001. 
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Table 2. Summary of logistic models developed to obtain propensity scores for each pair of 
ethnic/racial groups* 
 
Pair of ethnic groups being compared Hosmer-Lemeshow 
goodness-of-fit test  
χ2 (p value) 
Area under the ROC 
curve 
 
White and Black (n = 945) 
 
White and Hispanic (n = 934) 
 
Black and Hispanic (n = 433) 
 
 
5.4 (.7) 
 
8.0 (.4) 
 
3.1 (.9) 
 
0.80 
 
0.76 
 
0.88 
 
*The number of observations used for each model is given in parentheses after the label 
indicating which pair of ethnic/racial groups is being compared; respondents who were missing 
one or more of the predictor variables were not included in the analysis, so the number is smaller 
than the total of the two ethnic/racial groups. 
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Table 3. Repeated measures analysis of covariance models, with separate models for each pair of ethnic/racial groups* 
 
Covariate or Factor Black and White  
(combined n = 945) 
White and Hispanic  
(combined n = 934) 
Black and Hispanic  
(combined n = 433) 
 
Outcome:  Total score 
MLHFQ at baseline 
Propensity score 
Time (T) 
Ethnic group (E) 
T*E 
Treatment group (TG) 
T*TG 
E*TG 
T*E*TG 
 
Outcome:  Physical health subscale 
MLHFQ–PH at baseline 
Propensity score 
Time (T) 
Ethnic group (E) 
T*E 
Treatment group (TG) 
T*TG 
E*TG 
T*E*TG 
 
Outcome: Emotional health subscale 
MLHFQ–EH at baseline 
Propensity score 
Time (T) 
Ethnic group (E) 
T*E 
Treatment group (TG) 
T*TG 
E*TG 
T*E*TG 
F 
 
557.4 
24.9 
1.4 
0.5 
<.1 
10.7 
<.1 
1.1 
<.1 
 
 
354.3 
30.4 
0.7 
2.7 
0.2 
13.3 
<.1 
3.4 
0.3 
 
 
586.8 
8.9 
0.3 
<.1 
0.3 
7.0 
0.4 
0.3 
0.4 
p value 
 
<.0001 
<.0001 
.2 
.5 
>.9 
.001 
.8 
.3 
.9 
 
 
<.0001 
<.0001 
.4 
.1 
.7 
.0003 
.9 
.07 
.6 
 
 
<.0001 
.003 
.6 
.9 
.6 
.009 
.6 
.6 
.6 
F 
 
394.3 
16.1 
10.2 
57.5 
3.2 
6.5 
0.6 
1.0 
0.9 
 
 
232.6 
14.4 
3.5 
41.1 
1.8 
4.8 
1.3 
1.0 
0.1 
 
 
477.1 
8.0 
10.7 
41.3 
4.1 
5.8 
0.1 
0.4 
1.6 
p value 
 
<.0001 
<.0001 
.002 
<.0001 
.08 
.01 
.4 
.3 
.3 
 
 
<.0001 
.0002 
.06 
<.0001 
.2 
.03 
.3 
.3 
.7 
 
 
<.0001 
.005 
.001 
<.0001 
.04 
.02 
.7 
.6 
.2 
F 
 
269.9 
33.9 
3.3 
8.2 
1.7 
2.4 
0.3 
0.8 
0.2 
 
 
186.9 
34.0 
1.6 
3.7 
0.4 
4.5 
0.2 
3.1 
0.2 
 
 
232.5 
20.7 
1.9 
4.7 
4.0 
1.1 
0.3 
<.1 
<.1 
   p  value 
 
<.0001 
<.0001 
.07 
.004 
.2 
.1 
.6 
.4 
.7 
 
 
<.0001 
<.0001 
.2 
.06 
.5 
.04 
.6 
.08 
.7 
 
 
<.0001 
<.0001 
.2 
.03 
.05 
.3 
.6 
.9 
.9 
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*Ethnic group analyses are bolded for emphasis 
 
